Related Experiment Video
Updated: Jul 23, 2026

A Method for Screening and Validation of Resistant Mutations Against Kinase Inhibitors
Published on: December 7, 2014
Structural basis for the activity of pp60(c-src) protein tyrosine kinase inhibitors
N V Prabhu1, S A Siddiqui, J S McMurray
1Department of Chemistry, University of Houston, Houston, TX 77204-5641, USA.
Abstract:
Conformational searches on three closely related pp60(c-src) protein tyrosine kinase inhibitors of varying potencies were performed to determine a structural basis for their activity. The first was a linear peptide (PDNEYAFFQf), the second its 10-membered cyclic analogue, and the third a cyclic analogue with a para carboxyphenylalanine in place of one the F residues. A common backbone conformation with an antiparallel beta-sheet-like geometry capped by similar beta-turns was found for all three peptides, which may be a binding conformation and gives a candidate pharmacophore for further testing. The interaction between some polar side chains and between some of the aromatic rings may be important for maintaining the correct conformation. The differences in potencies of these inhibitors may be attributed to certain thermodynamic and chemical reasons.
Related Concept Videos
Inhibition of Cdk Activity
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Receptor Tyrosine Kinases
PI3K/mTOR/AKT Signaling Pathway
Inhibition of CDK Activity
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:

